Page 3 - Swedish (OMX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 30, 2024

Discover Swedish Pharmaceuticals & Biotech Growth Stocks that are on the OMX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

124 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ACE

Ascelia Pharma
kr10.58-15.6%-25.2%kr359.2mkr9.75PB4.8xE4.4%n/a

IRLAB A

IRLAB Therapeutics
kr11.40-0.9%16.6%kr591.3mkr56.45PS104.1xE-1.1%n/a

LIPUM

Lipum
kr7.0012.9%-35.8%kr148.5mkr15.00PB32.5xE-7.4%n/a

ELIC

Elicera Therapeutics
kr0.94-21.7%-73.1%kr33.0mn/aPS2.9xE-10.1%n/a

GENO

Genovis AB (publ.)
kr27.850.7%-52.2%kr1.8bkr50.50PE29.6xE-13.9%n/a

CYXO

Cyxone
kr0.0920.9%-87.1%kr19.8mn/aPS3.9xE-18.1%n/a

DMYD B

Diamyd Medical
kr10.6811.3%-46.6%kr1.1bkr21.00PS3886.4xE-21.0%n/a

ABLI

Abliva
kr0.171.8%-26.0%kr232.1mn/aPS1694.1xE-23.4%n/a

MODTX

Modus Therapeutics Holding
kr1.010.5%-57.2%kr36.1mn/aPB2xE-28.8%n/a

LPGO

Lipigon Pharmaceuticals
kr0.34-8.1%-33.3%kr43.0mkr2.50PS2.6xE-35.0%n/a

INDEX

InDex Pharmaceuticals Holding
kr0.3913.2%-1.5%kr209.9mn/aPS1.8xE-48.5%n/a

ALZ

Alzinova
kr1.12-38.9%-55.0%kr49.9mkr6.50PS2.5xE-57.5%n/a

KDEV

Karolinska Development
kr1.572.4%-6.1%kr422.6mkr4.05PE12.6xE-72.0%n/a

RESP

Respiratorius
kr0.240%-37.8%kr69.9mn/aPB2.6xS-39.9%n/a

ISAB

Inhalation Sciences Sweden
kr4.340%24.4%kr65.8mkr16.50PS3.8xS59.5%n/a

LIDDS

LIDDS
kr0.174.0%-86.6%kr11.6mn/aPB0.8xn/an/a

ABERA

Abera Bioscience
kr4.71-1.9%-5.8%kr72.3mkr11.80PS27.3xS10.3%n/a

ACOU

AcouSort
kr10.206.9%-39.3%kr152.3mn/aPS14.4xn/an/a

APTA

Aptahem
kr0.032.0%-91.6%kr13.7mn/aPS5.2xn/an/a

ATANA

Attana
kr0.081-2.4%-56.2%kr27.9mn/aPS4.6xn/an/a

NICA

Nanologica
kr5.700.7%-36.0%kr252.1mkr11.00PS31.8xS74.3%n/a

DBP B

Double Bond Pharmaceutical International
kr0.636.1%1.3%kr63.9mn/aPS46.6xn/an/a

ARCEDE

Arcede Pharma
kr0.097-5.4%-95.9%kr567.1kn/an/an/an/a

PMED

PEPTONIC medical
kr0.060%-27.7%kr92.1mn/aPS2.3xn/an/a
Page 3 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.